- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 3.87M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.09M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.26M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.37M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $230.36K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $2.59M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.45M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $16.2M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $12.46M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $18.22M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.72M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $11.34M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $29.43M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $34.06M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 3.85M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $1.13M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$4.42M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $153.85M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $165.02M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$2.90 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$2.90 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $2.39M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $73.85K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$11.16M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$2.53M |